0 Comments
0 Shares
911 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
ELEVIDYS: Transforming Duchenne Muscular Dystrophy Treatment ForeverThe approval of ELEVIDYS by Sarepta Therapeutics has ushered in a new era of hope for patients battling Duchenne Muscular Dystrophy (DMD). This innovative gene therapy, now approved by the FDA, addresses the underlying cause of the disease, making it a significant advancement in DMD therapeutic developments. Understanding Duchenne Muscular Dystrophy (DMD) Duchenne Muscular Dystrophy...0 Comments 0 Shares 859 Views 0 Reviews
-
Exon-Skipping to Gene Therapy: What's Next for Duchenne Muscular Dystrophy?Duchenne muscular dystrophy (DMD) is a rare, progressive neuromuscular disorder caused by mutations in the dystrophin gene. While exon-skipping therapies have played a key role in advancing the Duchenne muscular dystrophy treatment landscape, researchers are now exploring alternative therapeutic strategies to enhance patient outcomes. Existing Treatment Options for Duchenne Muscular...0 Comments 0 Shares 1K Views 0 Reviews
-
How Gene Therapy Could Transform Duchenne Muscular Dystrophy CareGene therapy is transforming Duchenne muscular dystrophy treatment, bringing new hope to patients with this progressive neuromuscular disorder. With continuous research and clinical advancements, advancements in Duchenne muscular dystrophy gene therapy are driving the development of potential long-term solutions. Duchenne Muscular Dystrophy Epidemiology: Understanding the...0 Comments 0 Shares 1K Views 0 Reviews